Breast milk vitamin A (BMVA) has been proposed as an indicator of population vitamin A status but has rarely been applied in large-scale surveys or compared with conventional vitamin A biomarkers. We assessed the prevalence of, and risk factors for, low BMVA and its relation to vitamin A intake, plasma retinol-binding protein (pRBP), and markers of inflammation in a national survey in Cameroon. We randomly selected 30 clusters in each of 3 strata (South, North, and Cities). Casual milk samples were collected from approximately 5 women per cluster (n = 440). pRBP, plasma C-reactive protein (pCRP), plasma a 1 -acid glycoprotein (pAGP), and 24-h vitamin A intake were assessed in 10 women aged 15-49 y and 10 children aged 12-59 mo per cluster, including a subset of lactating women (n = 253). Low BMVA was infrequent:
Introduction
Infants are born with low liver vitamin A stores, so breast milk is a critical source of vitamin A to support infant vitamin A status and health (1) . Breast milk vitamin A (BMVA) 7 is derived from both maternal vitamin A stores [as circulating plasma retinol (pROH) bound to plasma retinol-binding protein (pRBP) and transthyretin] and recent dietary intake (transferred directly to the mammary gland from chylomicrons) (2) (3) (4) . In previous studies, BMVA increased in response to high-dose vitamin A supplements (5-7) and small daily doses of vitamin A (7-10), including consumption of fortified foods (11, 12) . Because BMVA varies according to maternal vitamin A stores and intake, BMVA has been recommended as an indicator for assessing the vitamin A status of lactating women and their breastfed infants (13, 14) , as well as the response to vitamin A interventions. However, BMVA is seldom measured in large surveys, so there have been few opportunities to compare BMVA with other indicators of vitamin A status at the population level. pROH and pRBP are widely used indicators of population vitamin A status; however, their interpretation is complicated by the presence of inflammation, which leads to temporarily decreased pROH and pRBP concentrations (15) . It is currently unknown whether BMVA is similarly affected by concurrent inflammation. Theoretically, BMVA could decrease during inflammation if the contribution of pROH bound to pRBP diminishes. However, any effect of this decrease on BMVA may be negligible if the contribution of dietary vitamin A (and, possibly, accumulated mammary gland vitamin A) is large. There was no relation between BMVA (expressed as micromoles per liter) and inflammation, as measured by plasma C-reactive protein (pCRP) and plasma a 1 -acid glycoprotein (pAGP), at 2 wk postpartum among Malawian women (16) . However, milk fat content was not measured, and it is unknown whether the relation between BMVA and inflammation would be similar in early and late lactation. Vitamin A is present in the fat portion of the milk, which is highly variable, depending on the time since the previous breast feed, stage of lactation, and other factors (17) . Thus, standardized procedures are recommended for milk collection, as well as the measurement of milk fat concentration to express BMVA both per unit volume and per gram of fat (14) .
In the context of a national survey of dietary intake and micronutrient status of women and young children in Cameroon, we examined BMVA and the prevalence of low BMVA among lactating women, nationally and by potential geographic and socioeconomic risk factors. We compared the prevalence of low BMVA with the prevalence of vitamin A deficiency (VAD) among women and children, as measured by pRBP. We also investigated the relation between BMVA and maternal pRBP, maternal dietary intake, and the childÕs pRBP. Finally, we examined the association between BMVA and other physiologic and methodologic factors, including milk-fat concentration, the timing of milk collection (stage of lactation and fullness of the breast), and markers of inflammation.
Methods
Sampling design. The survey procedures have been described in detail previously (18) . Briefly, this was a nationally representative, multistage, cluster survey that was conducted to establish the baseline prevalence of micronutrient deficiencies before initiating a national food fortification program [n = 1002 households]. The country was divided into 3 geographic and ecologic regions: the North, consisting of the 3 northernmost provinces (North, Far North, and Adamoua), the South, consisting of the remaining 7 southern provinces, and Yaoundé and Douala, the 2 major urban areas. Within each region, 30 clusters were randomly selected according to the proportionate-to-population-size sampling method, and 10 households per cluster were selected using a random start point and systematic sampling of adjacent households. Households were eligible for the full study (dietary intake and micronutrient status) if a child aged 12-59 mo and the childÕs primary female caregiver (15-49 y) resided in the household. If the index woman was lactating, she was eligible to provide breast milk if the breastfed child was at least 1 mo old, the age when milk nutrient concentrations begin to stabilize (2) . Households were excluded if the index woman or child reported severe fever (as defined by the woman), diarrhea with dehydration, or other severe illness in the 72 h before data collection.
We estimated that 450 breast milk samples would be necessary to detect an effect size of 0.27 for the change in BMVA concentration at the national level before and after initiation of the national food fortification program (assuming a = 0.05, b = 0.20, and design effect = 2). Analysis of 2005 Demographic and Health Survey data suggested that ;30% of the women in the target age range would be lactating (i.e., on average, 3 of the 10 women selected from each cluster). Thus, to achieve the desired sample size for breast milk, we recruited approximately 2 to 3 additional lactating women per cluster, using the same sampling methodology described above. These additional women provided breast milk only and did not participate in the full study. One lactating woman reported being pregnant; exclusion of this individual did not affect the results so her data were included.
Informed verbal consent to participate was obtained from the index woman for herself and her child. Ethical approval for this study was granted by the National Ethics Committee of Cameroon and the Human Subjects Committee of the University of California, Davis.
Data collection. Trained interviewers elicited information on household demographic characteristics, indicators of socioeconomic status (SES) (e.g., possessions, occupation, educational level, etc.), receipt of postpartum vitamin A supplements, and dietary intake. Weights of women and children were measured to the nearest 0.1 kg by electronic scale (Seca 899; Seca Medical Scales and Measuring Systems). Heights of women and children $2 y were measured to the nearest 0.1 cm using a portable stadiometer (Seca Leicester Portable Height Measure; Seca Medical Scales and Measuring Systems), and length of children aged <2 y was measured to the nearest 0.1 cm using a length board (Seca 416 Infantometer; Seca Medical Scales and Measuring Systems).
Dietary interviews. Dietary data were collected by FFQ and 24-h dietary recall methods. The FFQ included only red palm oil (RPO) and 4 potentially fortifiable foods (refined vegetable oil, wheat flour, sugar, and bouillon cube). Respondents were asked how many days in the previous 7 d they consumed each food, either alone or in mixed dishes, and how many times they consumed the food on the most recent day on which the food was consumed. Weekly frequency of intake was then calculated as the product of the number of days per week multiplied by the number of times consumed per day.
The 24-h dietary recall used a multiple pass system in which the interviewer requested an increasing level of detail about all foods and beverages consumed by the index woman and child on the previous day (19) . An electronic scale, precalibrated local utensils (cups, bowls, etc.), and geometric food models were used to assist respondents in estimating the portion sizes consumed, and a list of pictures of local foods was used as a memory aid throughout the recall. For mixed dishes that were prepared in the household, information was collected on the amount of each ingredient added and the total amount prepared. Duplicate recalls were conducted in a ;10% subset of participants to estimate intraindividual variability in nutrient intake; however, as described below, only dietary intake on the day before milk collection was included in this analysis.
''Bleaching'' RPO (heating the oil until it becomes clear) before use in cooking is a common practice in parts of Cameroon. Because this process destroys the carotenoids present in the oil (20) , we also recorded whether the RPO was bleached or unbleached in the 24-h recalls (but not in the FFQ) and included only unbleached RPO in the calculation of vitamin A intake.
Biologic sample collection and processing. Retinol is present in the lipid portion of milk, which varies in concentration according to many factors independent of the motherÕs nutritional status (14, 17) . Thus, we standardized the portion of the feed at which milk was collected and measured milk-fat content to report BMVA both per unit volume and per gram of fat (14) . In addition, information on the age of the breastfed infant, time of day of milk collection, time since the motherÕs last meal, and time since the previous breast feed was obtained from each mother.
Breast milk was collected according to the casual sampling method (14) . Milk was collected from the breast from which the infant had not fed for a longer time (i.e., the ''fuller'' breast). The mother first allowed her child to feed from the breast from which milk was to be collected. After exactly 30 s, the mother manually expressed 5-10 mL of milk from the same breast.
Milk-fat concentration was measured in fresh milk by the ''Creamatocrit'' method (21) . Milk samples were aliquoted in triplicate into nonheparinized glass microhematocrit tubes and centrifuged at 1500 3 g for 15 min (Hermle Z-233 M-2; Hermle LaborTechnik). For each tube, the length of the lipid layer and the length of the entire milk ''column'' were measured in duplicate to the nearest 0.1 mm using vernier calipers. Lipid concentration in grams per liter was estimated from the lipid concentration by volume using a validated regression equation (21) . The median CV for duplicate measurements was 3.8% (mean = 4.9%). Milkfat concentration did not differ according to the technician performing the measurement.
Venous blood samples were collected from women (n = 872) and children (n = 838) who were eligible to participate in the full study but not from women who were recruited to provide breast milk only (n = 187). Plasma was separated within 2 h of collection by centrifugation at 2500 3 g for 10 min (Hermle Z206A; Hermle LaborTechnik).
Blood and milk samples were collected and stored in containers covered in aluminum foil, processed under dim light, and frozen on the day of collection. Samples were transported and stored at no more than 220°C until analysis at University of California, Davis (milk retinol and pROH) and the VitA-Iron laboratory in Germany (ELISA analyses).
Laboratory analyses. BMVA was measured using a reversed-phase HPLC system (Class VP; Shimadzu) (22, 23) . Milk samples were thawed at room temperature (;27°C), gently inverted, and then vortexed to homogenize the sample. Samples were saponified for 60 min at 60°C in ethanolic KOH with pyrogallol. Retinol was extracted into hexane, dried under nitrogen, and reconstituted in methanol before measurement using a 3-mm, C-18 column with a mobile phase of 68% acetonitrile, 20% isopropanol, and 12% methanol by volume. Retinol was detected at 325 nm using a photo-diode array detector. Retinal (O-ethyl) oxime was added as an internal standard after saponification and before extraction (24) . Infant formula from the National Institute of Standards and Technology (NIST) was analyzed along with each batch of breast milk samples according to the same procedures (NIST Standard Reference Material 1849, 3 to 4 NIST aliquots per batch). The retinol concentration of the NIST infant formula was verified by comparison with NIST serum with certified content of fat-soluble vitamins (NIST Standard Reference Material 968e). Retinol concentrations of the unknowns were calculated by comparing the ratio of retinol-to-retinal oxime in the NIST samples and the unknowns. The within-day and between-day CVs of 115 NIST controls were 3.5% and 8.9%, respectively (PROC VARCOMP; SAS Institute).
pRBP, pCRP, and pAGP concentrations were measured by ELISA (25) . The interassay CVs were as follows: pRBP, 2.7%; pCRP, 6.5%; and pAGP, 3.5%. Cutoffs to indicate VAD have been defined for pROH but not pRBP (13) . Although pRBP is the main carrier protein for pROH, the molar ratio of pROH-to-pRBP is not exactly 1:1. Thus, we measured pROH concentrations by HPLC in a subset of women and children and used regression analysis to derive population-specific cutoffs for pRBP equivalent to standard pROH cutoffs (26) .
Data analyses. Data were analyzed with SAS 9.3 (SAS Institute). Dietary intakes of energy, vitamin A, and fat were estimated using nutrient composition values from the Nutrient Data System for Research 2010 [developed by the Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN (27) ], supplemented with values from the HarvestPlus food composition table for Uganda (28) and the International Minilist (29) . For mixed dishes that were not prepared by the respondent, average recipes were constructed from the recipes collected from other respondents in the area. The type of oil used in a mixed dish (e.g., refined vegetable oil vs. unbleached RPO) varied by region and type of recipe; thus, for recipes prepared outside the home, we used logistic regression to model the probability that a specific average recipe consumed by a respondent in a specific area would contain unbleached RPO. Because only 1 d of dietary data were available for the majority of respondents, the dietary data presented should be considered measurements of individual intake on the previous day only and are not valid estimates of ''usual'' vitamin A intake at the individual level. However, because there is evidence that recent vitamin A intake may affect BMVA (4, 30) , it is reasonable to examine the relation between previous day vitamin A intake and BMVA. All analyses were conducted using SAS survey procedures and appropriate weighting factors to account for the sampling design. Continuous variables were assessed for adherence to a normal distribution (Shapiro-Wilk W > 0.97) and transformed when necessary. In this context, pRBP has 2 potential applications: 1) to indicate maternal vitamin A status (i.e., as an indirect indicator of low liver vitamin A stores); and 2) to indicate the amount of pRBP-bound retinol that is available to the mammary gland. For the purpose of estimating maternal vitamin A status, pRBP concentrations were adjusted for inflammation by multiplying pRBP values by populationspecific correction factors based on whether an individual had pCRP > 5 mg/L and pAGP # 1/gL (correction factor = 1.06), pCRP > 5 mg/L and pAGP > 1/gL (1.28), or pCRP # 5 mg/L and pAGP > 1 g/L (1.13) (15); a comparison of unadjusted and adjusted values has been reported previously (26) . Because BMVA per gram of fat was associated with pCRP, we also assessed the effect of adjusting BMVA concentrations for elevated pCRP using a similar method.
Low BMVA was defined as <1.05 mmol/L or <8 mg/g fat (<28 nmol/g fat) (13) . VAD was defined as pRBP < 0.83 mmol/L for children and <0.78 mmol/L for women (equivalent to pROH < 0.70 mmol/L) (26) . Low vitamin A status among women was defined as pRBP < 1.17 mmol/L (equivalent to pROH < 1.05 mmol/L) (26) . Values in the text are means 6 SEs or means (95% CIs), unless otherwise noted.
The relation between BMVA and pRBP, pCRP, pAGP, and other biologic indicators were examined using Spearman correlations and multiple linear regression analysis (PROC SURVEYREG; SAS Institute). BMVA concentrations and prevalence of low BMVA among risk groups were estimated by domain analysis and compared using linear and logistic regression analysis, respectively (PROC SURVEYREG and PROC SURVEYLOGISTIC; SAS Institute). Finally, we calculated sensitivity and specificity and used receiver operating characteristics (ROCs) analysis to assess the overall ability of BMVA to predict maternal pRBP values below the specified cutoffs.
Results
Within each stratum, milk fat and BMVA did not differ between women who participated in the full study, including blood collection (n = 253), and women who provided milk only (n = 187). Median vitamin A intake on the previous day (346 mg retinol activity equivalents) was low relative to the Institute of Medicine estimated average requirement of 900 mg retinol activity equivalents/d for lactating women (31) ( Table 1) . Because pRBP did not differ among lactating and nonlactating women (P = 0.27), pRBP values and prevalence of low pRBP values are presented for all women of reproductive age in subsequent tables; separate results for lactating women are available in Supplemental Tables 1 and 2 .
Both BMVA per liter (BMVA/L) and BMVA per gram (BMVA/g) of fat were associated with milk-fat content, maternal BMI, and variables related to the timing of milk collection ( Fig. 1; Table 2 ; values in the original scale are shown in Supplemental Fig. 1 ). Maternal BMI was positively associated with time elapsed since a previous breastfeed (r s = 0.21, P = 0.002), previous day vitamin A intake (r s = 0.23, P < 0.001), and inflammation-adjusted pRBP (r s = 0.26, P < 0.001). Reported receipt of a maternal postpartum vitamin A supplement was not related to BMVA, before or after controlling for the methodologic factors identified in the multivariate regression models.
After controlling for the methodologic factors identified above, including milk-fat content, both BMVA/L and BMVA/g fat were negatively related to pCRP [b = 20.03 6 0.01, P < 0.02 for ln(BMVA/L) and ln(BMVA/g fat), controlling for methodologic factors identified in Table 2 ] (adjusted and unadjusted models are presented in Supplemental Table 3 ). In contrast, BMVA, expressed either as micromoles per liter or micrograms per gram fat, was not associated with pAGP concentration, with or without controlling for methodologic variables (P > 0.3). BMVA was lower among women with pCRP > 5 mg/L than among those with pCRP # 5 mg/L only when expressed as micrograms per gram fat (3.11 6 0.36 vs. 4.00 6 0.19 mmol/L, P = 0.06, and 17.0 6 1.6 vs. 24.4 6 0.9 mg/g fat, P < 0.001).
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When unadjusted pRBP was added to the simple linear regression model of ln(BMVA/g fat) = pCRP (b = 20.03 6 0.01, P = 0.01), the pCRP term became nonsignificant (b = 20.02 6 0.01, P = 0.14), suggesting that the relation between pCRP and BMVA is mediated by decreased pRBP concentrations (Supplemental Table 3 ). Adjustment of BMVA for the presence of elevated pCRP did not significantly change the prevalence of low BMVA ( Table 3) .
In general, low BMVA, expressed either as <1.05 mmol/L or <8 mg/g fat, was infrequent (Table 3 ). In the South and Yaoundé/ Douala, <10% of women had BMVA < 8 mg/g fat, which is consistent with the WHO categorization of VAD as a mild public health problem [defined as <10% of women with BMVA < 1.05 mmol/L or <8 mg/g fat (13)]. In contrast, 26% of women in the North had BMVA < 8 mg/g fat, which is indicative of a severe public health problem [defined as >25% prevalence of BMVA < 1.05 mmol/L or <8 mg/g fat (13)]. Although the WHO did not include recommendations for defining a public health problem based on prevalence of low pROH levels among women, the pRBP concentrations among women also suggest that VAD is a public health problem among women only in the North region (Table 3 ). In contrast, the prevalence of low pRBP among children aged 12-59 mo (35%) reflects a severe public health problem in all regions according to the WHO classification [>20% with pROH < 0.7 mmol/L (13)].
We compared risk factors for low BMVA, low maternal pRBP, and low child pRBP to assess whether BMVA identified the same risk groups as pRBP ( Table 4 ). All indicators suggest that vitamin A status is lowest in the North region and among households in which the caregiver has no formal education. Only BMVA/g fat was lower among women in rural areas compared with urban areas. Women in the lowest vitamin A intake tertile had lower BMVA and lower pRBP than women in the middle and highest tertile of vitamin A intake, but the childÕs pRBP did not differ among tertiles of 24-h maternal dietary vitamin A intake, with or without controlling for child age and breastfeeding status. Similarly, women, but not children, in the lowest SES quintile had lower vitamin A status than women in higher SES quintiles. Maternal age and presence of stunting in the index child were not related to BMVA or maternal or child pRBP.
Overall, BMVA was positively associated with maternal pRBP, with or without adjustment for inflammation ( Fig. 2 ; In linear regression analysis, vitamin A intake on the previous day was positively associated with BMVA, with or without controlling for the methodologic variables identified above (without covariates, R 2 = 0.07 for BMVA/L; R 2 = 0.13 for BMVA/g fat; P < 0.001 for both). In addition, women who reported consuming any RPO in the previous week had higher BMVA than women who did not consume RPO in the previous week, even after controlling for total vitamin A intake on the previous day (Table 4 ). There was no relation between dietary fat or percentage of energy from animal source foods on the previous day and BMVA or pRBP concentrations.
To examine the relative contributions of maternal vitamin A status and vitamin A intake to BMVA, we modeled BMVA as a function of vitamin A intake on the previous day, concentrations of pRBP, pCRP, and pAGP, vitamin A supplement receipt postpartum, and methodologic factors that were related to BMVA (milk fat, time since previous feed, time of day of milk collection, and maternal BMI), as well as relevant interactions. We used backward stepwise elimination to obtain a final model of significant, independent predictors of BMVA. The final regression models for BMVA included the same predictor variables, regardless of whether BMVA was expressed as micromoles per liter and micrograms per gram fat: milk-fat content, pCRP concentration, inflammation-adjusted pRBP concentration, previous day vitamin A intake, and an interaction between pRBP and previous day vitamin A intake ( Table 6 ; Supplemental Table 4 ). After stratification by vitamin A intake in the previous 24 h, BMVA was positively associated with inflammation-adjusted pRBP among women in the lowest vitamin A intake tertile but not in the highest vitamin A intake tertile (Table 5) .
Among the households in the full study in which the index woman was lactating and the index child was receiving breast milk, BMVA/L (but not BMVA/g) fat was associated with inflammation-adjusted child pRBP, with or without controlling for child age [R 2 = 0.15, P = 0.046 for ln(BMVA/L); R 2 = 0.14, P = 0.08 for ln(BMVA/g fat); n = 43, controlling for child age]. However, BMVA was not associated with inflammationadjusted pRBP among the index children who were no longer breastfeeding but whose mothers provided breast milk (i.e., the mothers were breastfeeding a younger sibling of the index child) [R 2 = 0.04, P = 0.06, n = 121 for ln(BMVA/L); R 2 = 0.02, P = 0.41, n = 116 for ln(BMVA/g fat), controlling for child age]. were not significant in any of the final models and were thus removed. For sqrt(milk fat), R 2 = 0.07 and n = 192; for ln(breast milk vitamin A/L), R 2 = 0.27 and n = 213; and for ln (breast milk vitamin A/g fat), R 2 = 0.19 and n = 235. sqrt, square root. 
Discussion
Both pRBP and BMVA suggest that VAD is infrequent among Cameroonian lactating women, as well as women of reproductive age in general, but that low vitamin A status is most common in the North region. Thus, BMVA seems to be a good indicator of the extent of VAD among women. In contrast, the high prevalence (>20%) of low pRBP among children aged 12-59 mo in all regions suggests that VAD is an important public health problem among children (13) . Thus, in this population, measurement of BMVA only, without collection of blood samples from children, would greatly underestimate the magnitude of VAD among children. Nevertheless, both BMVA and child pRBP identified the North region and households in which the caregiver had no formal education as most likely to have low vitamin A status, so it is possible that BMVA could be used to target areas where children aged 12-59 mo may benefit from interventions to improve vitamin A status. Among women, other risk factors for both low BMVA and low pRBP included low maternal education, low maternal vitamin A intake, low SES, and, for BMVA/g fat only, residence in a rural area.
BMVA, expressed either as micromoles per liter or micrograms per gram fat, was positively associated with maternal pRBP, with or without adjustment of pRBP concentrations for inflammation; this relation has been noted in previous studies (7, 16) . However, the relation between BMVA and pRBP differed by vitamin A intake in the previous 24 h: pRBP was associated with BMVA among women with lower vitamin A intake but not among women with higher vitamin A intake. This observation seems reasonable given the possible independent variation in each of the 2 sources of retinol to the mammary gland (pRBP and chylomicrons). The contribution of pRBP to BMVA is theoretically dependent on the availability of holo-pRBP secreted by the liver, which is homeostatically controlled. In contrast, the contribution of dietary vitamin A to BMVA via chylomicrons does not seem to be regulated and could contribute large amounts of vitamin A to breast milk if daily vitamin A intake is high (32) . Thus, if the contribution of dietary vitamin A to BMVA is large, it may mask the association between BMVA and pRBP. This observation further suggests that increased dietary vitamin A intake could increase BMVA concentrations quickly even among women with low liver stores. Consistent with other studies, we found a relation between BMVA and methodologic factors, such as milk-fat content, time of day of collection, and time since the previous breastfeed (17) . Thus, it is important to measure and/or control for these factors in studies that measure BMVA; guidelines on this topic are available (14) .
We did not observe a relation between receipt of postpartum vitamin A supplement and BMVA, likely because the average time elapsed since supplementation was ;9 mo. In supplementation studies, the effect of postpartum vitamin A supplementation on BMVA generally disappeared by 6 mo (6,7).
It should be noted that our estimates of vitamin A intake represent consumption in the previous 24 h only and do not represent usual dietary vitamin A intake. Because there is evidence that BMVA responds rapidly to dietary intake (30, 33) , we considered it appropriate to explore the relation between vitamin A intake on the previous day and BMVA.
BMVA was negatively associated with pCRP concentrations only after controlling for milk-fat concentration. Thus, accounting for milk fat may explain the discrepancy between these results and those of another study that found no relation between BMVA and pCRP at 2 wk postpartum (16) . BMVA at 2 wk postpartum may also be influenced by conditions during pregnancy and thus less likely to reflect a change in pRBP attributable to acute infection.
It is possible that acute infection temporarily decreases BMVA concentrations via a decrease in pRBP. When pRBP was added to a regression model of the relation between pCRP and BMVA, the effect of pCRP was no longer significant, suggesting that the effect of pCRP may have been mediated via a decrease in pRBP. Dietary vitamin A intake on the previous day was not different among women with and without elevated acute-phase proteins, suggesting that the association of BMVA with pCRP does not simply reflect lower vitamin A intake. However, it is still possible that the association between BMVA and pCRP is attributable to differences in long-term diet and SES rather than a biologic relation. In any case, the apparent effect of pCRP was small, and adjusting BMVA concentrations for the presence of elevated pCRP did not appreciably change BMVA concentrations or prevalence of low BMVA. Thus, inflammation may not undermine the utility of BMVA, but more data are needed to understand these relations, particularly in populations with lower vitamin A status.
ROC analysis indicated that the sensitivity and specificity of BMVA to predict low inflammation-adjusted pRBP concentrations among women were low to moderate across a range of BMVA cutoffs, suggesting that BMVA may be less useful for targeting individuals (rather than population subgroups) at risk of VAD, although pRBP itself is a limited indicator of individual vitamin A status. We used a cutoff of pRBP < 1.17 mmol/L as the reference for this analysis because there were only a few women with pRBP < 0.78 mmol/L. The sensitivity and specificity for The choice of indicator to assess vitamin A status in a population will depend on the study context (i.e., field conditions, available funds, likely extent of VAD) as well as the purpose (to estimate prevalence of deficiency, identify high-risk groups, or evaluate the response to an intervention). Either pRBP or BMVA seems to be useful for identifying population subgroups at risk of low vitamin A status and/or intake, but BMVA has several potential advantages over pROH or pRBP. Collection of casual milk samples is considered to be easier than blood collection because milk collection requires fewer and less specific supplies and less training of sample collection technicians and may be more acceptable to participants in some contexts. In addition, BMVA appears to be less affected by inflammation than pROH or pRBP, although this needs to be verified in other populations. Although the public health conclusions were generally the same with BMVA/L compared with BMVA/g fat in this study, controlling for milk fat appeared to amplify the regional differences in prevalence of low BMVA; in addition, some relations (such as between BMVA and pCRP) were only apparent after controlling for milk fat. Thus, BMVA analysis requires measuring milk-fat concentration and ideally collecting information on variables such as time since a previous feed. Finally, in this population, neither BMVA nor maternal pRBP reflected the extent of VAD among children aged 12-59 mo (the majority of whom were no longer breastfeeding). It is possible that BMVA could be used to assess the situation of exclusively or predominantly breastfed children (for whom breast milk is a major source of dietary vitamin A), but we did not have adequate sample size to precisely estimate the prevalence of VAD in this subgroup. In any case, nonbreastfed children should be examined separately in studies of population vitamin A status. were time postpartum (infant age), time elapsed since previous breastfeed, time of day of milk collection, BMI, a 1 -acid glycoprotein, receipt of high-dose vitamin A supplement within 6 wk postpartum, interaction between time postpartum and milk fat, and interactions between BMI and previous day vitamin A intake, inflammationadjusted pRBP, and milk fat. pRBP values were adjusted for inflammation according to Thurnham et al. (15) . pRBP, plasma retinol-binding protein; RAE, retinol activity equivalent; sqrt, square root.
